Results 101 to 110 of about 51,731 (234)

Atorvastatin [PDF]

Reactions Weekly, 2020
  +5 more sources

Atorvastatin compared with simvastatin-based therapies in the management of severe familial hyperlipidaemias

, 1999
We compared atorvastatin with simvastatin-based therapies in a prospective observational study of 201 patients with severe hyperlipidaemia. Atorvastatin 10 mg therapy was substituted for simvastatin 20 mg, 20 mg for 40 mg, 40 mg for simvastatin 40 mg ...
Lumb, P J, Semra, Y, Crook, M A, Wierzbicki, A S, Christ, E R, Chik, G   +5 more
core   +1 more source

Understanding exosomes in diabetic wound healing

Periodontology 2000, EarlyView.
Abstract Background Diabetic wounds signify a major complication of diabetes mellitus, characterized by chronic inflammation, compromised angiogenesis, and high risk of infection, amputation, and mortality. Contemporary therapies remain limited in efficacy and durability.
Paras Ahmad, Yulan Wang, Yufeng Zhang, Anton Sculean, Richard J. Miron   +4 more
wiley   +1 more source

Atorvastatin and flaxseed dietary treatments improve dyslipidemia and liver injuries in a diet-induced rat model of non-alcoholic fatty liver disease [PDF]

Avicenna Journal of Phytomedicine
Objective: Non-alcoholic fatty liver disease (NAFLD) as the most common chronic liver disease is associated with metabolic disorders including dysregulated lipid and glucose metabolism.
Zahra Eslami, Hamidreza Joshaghani, Abdorreza Eghbal Moghanlou, Alireza Norouzi, Seyed Javad Mirghani   +4 more
doaj   +1 more source

Simultaneous administration of high-dose atorvastatin and clopidogrel does not interfere with platelet inhibition during percutaneous coronary intervention

, 2016
Rolf P Kreutz,1,2 Jeffrey A Breall,1 Anjan Sinha,1 Elisabeth von der Lohe,1 Richard J Kovacs,1 David A Flockhart,2,† 1Krannert Institute of Cardiology, 2Division of Clinical Pharmacology, Indiana University School of Medicine, Indianapolis, IN ...
Breall JA, Sinha A, Flockhart DA, Kovacs RJ, Kreutz RP, von der Lohe E   +5 more
core  

Effects of non‐surgical periodontal therapy on intrabony periodontal defects at different re‐evaluation time points: A systematic review of randomized controlled trials and clinical recommendations

Periodontology 2000, EarlyView.
Abstract Objective The aim of this systematic review and meta‐analysis was to evaluate the longitudinal temporal pattern of periodontal probing depth (PPD) reduction in intrabony periodontal defects following non‐surgical periodontal therapy (NSPT), both as a monotherapy and with adjunctive locally delivered pharmacological agents.
Luca Ramaglia, Vincenzo Iorio‐Siciliano, Leopoldo Mauriello, Andrea Blasi, Anton Sculean   +4 more
wiley   +1 more source

Optimized zein nanospheres for improved oral bioavailability of atorvastatin

International Journal of Nanomedicine, 2015
Fahima M Hashem,1 Majid M Al-Sawahli,2 Mohamed Nasr,1 Osama AA Ahmed3,4 1Department of Pharmaceutics and Industrial Pharmacy, Faculty of Pharmacy, Helwan University, Cairo, 2Holding Company for Biological Products and Vaccines, Giza, Egypt; 3Department ...
Hashem FM, Al-Sawahli MM, Nasr M, Ahmed OA   +3 more
doaj  

Atorvastatin and cardiovascular risk in the elderly – patient considerations

, 2008
Subroto Acharjee, Francine K WeltyDivision of Cardiology, Beth Israel Deaconess Medical Center, Boston, MA, USAAbstract: Elderly individuals are at increased risk of coronary heart disease (CHD) and account for a majority of CHD deaths.
Subroto Acharjee, Francine K Welty
core  

The effects of uninterrupted and interrupted sitting on blood pressure and arterial stiffness in patients with established coronary heart disease

Experimental Physiology, EarlyView.
Abstract Sedentary behaviour is an independent risk factor for cardiovascular disease. In healthy adults, prolonged uninterrupted sitting acutely increases blood pressure (BP) and aortic stiffness; however, these effects can be mitigated with light physical activity interruptions.
Simon Fryer, Eve Scarle, Louise Turner, Arsalan Moinuddin, James Faulkner, Hayley Legg, Craig Paterson, Keeron Stone   +7 more
wiley   +1 more source

Torcetrapib does not reduce atherosclerosis beyond atorvastatin and induces more proinflammatory lesions than atorvastatin

, 2008
BACKGROUND - Although cholesteryl ester transfer protein (CETP) inhibition is regarded as a promising strategy to reduce atherosclerosis by increasing high-density lipoprotein cholesterol, the CETP inhibitor torcetrapib given in addition to atorvastatin ...
Hoogt, C.C. van der, Jukema, J.W., Romijn, Johannes A., de Haan, Willeke, de Vries-van der Weij, Jitske, Romijn, J.A., Havekes, Louis M., Hoorn, J.W.A. van der, Westerterp, Marit; id_orcid, Rensen, P.C.N., Jukema, J. Wouter, Vries-van der Weij, J. de, Havekes, L.M., van der Hoogt, Caroline C., Gautier, Thomas, Haan, W. de, Rensen, Patrick C. N., van der Hoorn, Jose W. A., Westerterp, M., Gautier, T., Princen, H.M.G., Princen, Hans M. G., Westerterp, Marit   +22 more
core   +1 more source